Europe Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Product, By End User, Based on Specimen, By Technology, By Application (Research, Clinical, and Drug/Therapy Development), By Country and Growth Forecast, 2024 - 2031
Published Date : 17-Jan-2025 |
Pages: 122 |
Report Format: PDF + Excel |
COVID-19 Impact on the Europe Circulating Tumor Cell Market
Market Overview
The Europe Circulating Tumor Cell Market would witness market growth of 13.0% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Circulating Tumour Cell Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,842.2 million by 2031. UK market is exhibiting a CAGR of 12.1% during (2024 - 2031). Additionally, The France market would experience a CAGR of 13.9% during (2024 - 2031).
The adoption of CTC-based technologies has grown significantly over the past few years, driven by advances in liquid biopsy techniques, an increasing understanding of cancer biology, and a rising demand for less invasive diagnostic methods. Significant breakthroughs in CTC isolation and detection technologies, such as microfluidics, immunomagnetic capture, and imaging techniques, have enabled the accurate and efficient collection of CTCs from blood samples.
Moreover, innovations in molecular analysis, such as next-generation sequencing (NGS) and single-cell RNA sequencing, have further enhanced the ability to profile CTCs and gain insights into their genetic makeup.
The rising incidence of prostate and bladder cancer in Europe is driving a growing demand for advanced diagnostic and monitoring solutions, such as circulating tumor cell technologies. With prostate cancer being the most common cancer among men and bladder cancer ranking fifth in terms of prevalence, there is an urgent need for effective early detection and non-invasive diagnostic methods.
Free Valuable Insights: The Global Circulating Tumor Cell Market will Hit USD 29.42 Billion by 2031, at a CAGR of 13.2%
Based on Product, the market is segmented into Kits & Reagents, Devices, and Blood Collection Tubes. Based on End User, the market is segmented into Research and Academic Institutes, Hospital & Clinics, and Diagnostic Centers. Based on Specimen, the market is segmented into Blood, Bone Marrow, and Other Specimen. Based on Technology, the market is segmented into CTC Detection & Enrichment Methods, CTC Analysis, and CTC Direct Detection. Based on Application, the market is segmented into Research, Clinical, and Drug/Therapy Development. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Qiagen N.V
- Greiner Bio-One International GmbH
- Sysmex Corporation
- Miltenyi Biotech B.V & Co kg
- Bio-Techne Corporation
- Ikonisys, Inc.
- Menarini Silicon Biosystems SpA
- LungLife AI Inc.
- Aviva Systems Biology Corporation
- ScreenCell
Europe Circulating Tumor Cell Market Report Segmentation
By Product
- Kits & Reagents
- Devices
- Blood Collection Tubes
By End User
- Research and Academic Institutes
- Hospital & Clinics
- Diagnostic Centers
By Specimen
- Blood
- Bone Marrow
- Other Specimen
By Technology
- CTC Detection & Enrichment Methods
- CTC Analysis
- CTC Direct Detection
By Application
- Research, Clinical
- Drug/Therapy Development
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Circulating Tumor Cell Market, by Product
1.4.2 Europe Circulating Tumor Cell Market, by End User
1.4.3 Europe Circulating Tumor Cell Market, by Specimen
1.4.4 Europe Circulating Tumor Cell Market, by Technology
1.4.5 Europe Circulating Tumor Cell Market, by Application
1.4.6 Europe Circulating Tumor Cell Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Circulating Tumor Cell Market by Product
4.1 Europe Kits & Reagents Market by Country
4.2 Europe Devices Market by Country
4.3 Europe Blood Collection Tubes Market by Country
Chapter 5. Europe Circulating Tumor Cell Market by End User
5.1 Europe Research and Academic Institutes Market by Country
5.2 Europe Hospital & Clinics Market by Country
5.3 Europe Diagnostic Centers Market by Country
Chapter 6. Europe Circulating Tumor Cell Market by Specimen
6.1 Europe Blood Market by Country
6.2 Europe Bone Marrow Market by Country
6.3 Europe Other Specimen Market by Country
Chapter 7. Europe Circulating Tumor Cell Market by Technology
7.1 Europe CTC Detection & Enrichment Methods Market by Country
7.2 Europe CTC Analysis Market by Country
7.3 Europe CTC Direct Detection Market by Country
Chapter 8. Europe Circulating Tumor Cell Market by Application
8.1 Europe Research, Clinical Market by Country
8.2 Europe Drug/Therapy Development Market by Country
Chapter 9. Europe Circulating Tumor Cell Market by Country
9.1 Germany Circulating Tumor Cell Market
9.1.1 Germany Circulating Tumor Cell Market by Product
9.1.2 Germany Circulating Tumor Cell Market by End User
9.1.3 Germany Circulating Tumor Cell Market by Specimen
9.1.4 Germany Circulating Tumor Cell Market by Technology
9.1.5 Germany Circulating Tumor Cell Market by Application
9.2 UK Circulating Tumor Cell Market
9.2.1 UK Circulating Tumor Cell Market by Product
9.2.2 UK Circulating Tumor Cell Market by End User
9.2.3 UK Circulating Tumor Cell Market by Specimen
9.2.4 UK Circulating Tumor Cell Market by Technology
9.2.5 UK Circulating Tumor Cell Market by Application
9.3 France Circulating Tumor Cell Market
9.3.1 France Circulating Tumor Cell Market by Product
9.3.2 France Circulating Tumor Cell Market by End User
9.3.3 France Circulating Tumor Cell Market by Specimen
9.3.4 France Circulating Tumor Cell Market by Technology
9.3.5 France Circulating Tumor Cell Market by Application
9.4 Russia Circulating Tumor Cell Market
9.4.1 Russia Circulating Tumor Cell Market by Product
9.4.2 Russia Circulating Tumor Cell Market by End User
9.4.3 Russia Circulating Tumor Cell Market by Specimen
9.4.4 Russia Circulating Tumor Cell Market by Technology
9.4.5 Russia Circulating Tumor Cell Market by Application
9.5 Spain Circulating Tumor Cell Market
9.5.1 Spain Circulating Tumor Cell Market by Product
9.5.2 Spain Circulating Tumor Cell Market by End User
9.5.3 Spain Circulating Tumor Cell Market by Specimen
9.5.4 Spain Circulating Tumor Cell Market by Technology
9.5.5 Spain Circulating Tumor Cell Market by Application
9.6 Italy Circulating Tumor Cell Market
9.6.1 Italy Circulating Tumor Cell Market by Product
9.6.2 Italy Circulating Tumor Cell Market by End User
9.6.3 Italy Circulating Tumor Cell Market by Specimen
9.6.4 Italy Circulating Tumor Cell Market by Technology
9.6.5 Italy Circulating Tumor Cell Market by Application
9.7 Rest of Europe Circulating Tumor Cell Market
9.7.1 Rest of Europe Circulating Tumor Cell Market by Product
9.7.2 Rest of Europe Circulating Tumor Cell Market by End User
9.7.3 Rest of Europe Circulating Tumor Cell Market by Specimen
9.7.4 Rest of Europe Circulating Tumor Cell Market by Technology
9.7.5 Rest of Europe Circulating Tumor Cell Market by Application
Chapter 10. Company Profiles
10.1 Qiagen N.V.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.6 SWOT Analysis
10.2 Greiner Bio-One International GmbH
10.2.1 Company Overview
10.2.2 SWOT Analysis
10.3 Sysmex Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Research & Development Expenses
10.3.4 SWOT Analysis
10.4 Miltenyi Biotech B.V. & Co. KG
10.4.1 Company Overview
10.4.2 SWOT Analysis
10.5 Bio-Techne Corporation
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Ikonisys, Inc.
10.6.1 Company Overview
10.7 Menarini Silicon Biosystems SpA
10.7.1 Company Overview
10.8 LungLife AI Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.9 Aviva Systems Biology Corporation
10.9.1 Company Overview
10.10. ScreenCell
10.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Circulating Tumor Cell Market, by Product
1.4.2 Europe Circulating Tumor Cell Market, by End User
1.4.3 Europe Circulating Tumor Cell Market, by Specimen
1.4.4 Europe Circulating Tumor Cell Market, by Technology
1.4.5 Europe Circulating Tumor Cell Market, by Application
1.4.6 Europe Circulating Tumor Cell Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Circulating Tumor Cell Market by Product
4.1 Europe Kits & Reagents Market by Country
4.2 Europe Devices Market by Country
4.3 Europe Blood Collection Tubes Market by Country
Chapter 5. Europe Circulating Tumor Cell Market by End User
5.1 Europe Research and Academic Institutes Market by Country
5.2 Europe Hospital & Clinics Market by Country
5.3 Europe Diagnostic Centers Market by Country
Chapter 6. Europe Circulating Tumor Cell Market by Specimen
6.1 Europe Blood Market by Country
6.2 Europe Bone Marrow Market by Country
6.3 Europe Other Specimen Market by Country
Chapter 7. Europe Circulating Tumor Cell Market by Technology
7.1 Europe CTC Detection & Enrichment Methods Market by Country
7.2 Europe CTC Analysis Market by Country
7.3 Europe CTC Direct Detection Market by Country
Chapter 8. Europe Circulating Tumor Cell Market by Application
8.1 Europe Research, Clinical Market by Country
8.2 Europe Drug/Therapy Development Market by Country
Chapter 9. Europe Circulating Tumor Cell Market by Country
9.1 Germany Circulating Tumor Cell Market
9.1.1 Germany Circulating Tumor Cell Market by Product
9.1.2 Germany Circulating Tumor Cell Market by End User
9.1.3 Germany Circulating Tumor Cell Market by Specimen
9.1.4 Germany Circulating Tumor Cell Market by Technology
9.1.5 Germany Circulating Tumor Cell Market by Application
9.2 UK Circulating Tumor Cell Market
9.2.1 UK Circulating Tumor Cell Market by Product
9.2.2 UK Circulating Tumor Cell Market by End User
9.2.3 UK Circulating Tumor Cell Market by Specimen
9.2.4 UK Circulating Tumor Cell Market by Technology
9.2.5 UK Circulating Tumor Cell Market by Application
9.3 France Circulating Tumor Cell Market
9.3.1 France Circulating Tumor Cell Market by Product
9.3.2 France Circulating Tumor Cell Market by End User
9.3.3 France Circulating Tumor Cell Market by Specimen
9.3.4 France Circulating Tumor Cell Market by Technology
9.3.5 France Circulating Tumor Cell Market by Application
9.4 Russia Circulating Tumor Cell Market
9.4.1 Russia Circulating Tumor Cell Market by Product
9.4.2 Russia Circulating Tumor Cell Market by End User
9.4.3 Russia Circulating Tumor Cell Market by Specimen
9.4.4 Russia Circulating Tumor Cell Market by Technology
9.4.5 Russia Circulating Tumor Cell Market by Application
9.5 Spain Circulating Tumor Cell Market
9.5.1 Spain Circulating Tumor Cell Market by Product
9.5.2 Spain Circulating Tumor Cell Market by End User
9.5.3 Spain Circulating Tumor Cell Market by Specimen
9.5.4 Spain Circulating Tumor Cell Market by Technology
9.5.5 Spain Circulating Tumor Cell Market by Application
9.6 Italy Circulating Tumor Cell Market
9.6.1 Italy Circulating Tumor Cell Market by Product
9.6.2 Italy Circulating Tumor Cell Market by End User
9.6.3 Italy Circulating Tumor Cell Market by Specimen
9.6.4 Italy Circulating Tumor Cell Market by Technology
9.6.5 Italy Circulating Tumor Cell Market by Application
9.7 Rest of Europe Circulating Tumor Cell Market
9.7.1 Rest of Europe Circulating Tumor Cell Market by Product
9.7.2 Rest of Europe Circulating Tumor Cell Market by End User
9.7.3 Rest of Europe Circulating Tumor Cell Market by Specimen
9.7.4 Rest of Europe Circulating Tumor Cell Market by Technology
9.7.5 Rest of Europe Circulating Tumor Cell Market by Application
Chapter 10. Company Profiles
10.1 Qiagen N.V.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.6 SWOT Analysis
10.2 Greiner Bio-One International GmbH
10.2.1 Company Overview
10.2.2 SWOT Analysis
10.3 Sysmex Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Research & Development Expenses
10.3.4 SWOT Analysis
10.4 Miltenyi Biotech B.V. & Co. KG
10.4.1 Company Overview
10.4.2 SWOT Analysis
10.5 Bio-Techne Corporation
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Ikonisys, Inc.
10.6.1 Company Overview
10.7 Menarini Silicon Biosystems SpA
10.7.1 Company Overview
10.8 LungLife AI Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.9 Aviva Systems Biology Corporation
10.9.1 Company Overview
10.10. ScreenCell
10.10.1 Company Overview
List of Tables
TABLE 1 Europe Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 2 Europe Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 3 Europe Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 4 Europe Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 5 Europe Kits & Reagents Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Kits & Reagents Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Devices Market by Country, 2020 - 2023, USD Million
TABLE 8 Europe Devices Market by Country, 2024 - 2031, USD Million
TABLE 9 Europe Blood Collection Tubes Market by Country, 2020 - 2023, USD Million
TABLE 10 Europe Blood Collection Tubes Market by Country, 2024 - 2031, USD Million
TABLE 11 Europe Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 12 Europe Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 13 Europe Research and Academic Institutes Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe Research and Academic Institutes Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Hospital & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Hospital & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Diagnostic Centers Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Diagnostic Centers Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 20 Europe Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 21 Europe Blood Market by Country, 2020 - 2023, USD Million
TABLE 22 Europe Blood Market by Country, 2024 - 2031, USD Million
TABLE 23 Europe Bone Marrow Market by Country, 2020 - 2023, USD Million
TABLE 24 Europe Bone Marrow Market by Country, 2024 - 2031, USD Million
TABLE 25 Europe Other Specimen Market by Country, 2020 - 2023, USD Million
TABLE 26 Europe Other Specimen Market by Country, 2024 - 2031, USD Million
TABLE 27 Europe Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 28 Europe Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 29 Europe CTC Detection & Enrichment Methods Market by Country, 2020 - 2023, USD Million
TABLE 30 Europe CTC Detection & Enrichment Methods Market by Country, 2024 - 2031, USD Million
TABLE 31 Europe CTC Analysis Market by Country, 2020 - 2023, USD Million
TABLE 32 Europe CTC Analysis Market by Country, 2024 - 2031, USD Million
TABLE 33 Europe CTC Direct Detection Market by Country, 2020 - 2023, USD Million
TABLE 34 Europe CTC Direct Detection Market by Country, 2024 - 2031, USD Million
TABLE 35 Europe Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 36 Europe Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 37 Europe Research, Clinical Market by Country, 2020 - 2023, USD Million
TABLE 38 Europe Research, Clinical Market by Country, 2024 - 2031, USD Million
TABLE 39 Europe Drug/Therapy Development Market by Country, 2020 - 2023, USD Million
TABLE 40 Europe Drug/Therapy Development Market by Country, 2024 - 2031, USD Million
TABLE 41 Europe Circulating Tumor Cell Market by Country, 2020 - 2023, USD Million
TABLE 42 Europe Circulating Tumor Cell Market by Country, 2024 - 2031, USD Million
TABLE 43 Germany Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 44 Germany Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 45 Germany Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 46 Germany Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 47 Germany Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 48 Germany Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 49 Germany Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 50 Germany Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 51 Germany Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 52 Germany Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 53 Germany Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 54 Germany Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 55 UK Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 56 UK Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 57 UK Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 58 UK Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 59 UK Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 60 UK Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 61 UK Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 62 UK Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 63 UK Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 64 UK Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 65 UK Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 66 UK Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 67 France Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 68 France Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 69 France Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 70 France Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 71 France Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 72 France Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 73 France Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 74 France Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 75 France Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 76 France Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 77 France Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 78 France Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 79 Russia Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 80 Russia Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 81 Russia Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 82 Russia Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 83 Russia Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 84 Russia Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 85 Russia Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 86 Russia Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 87 Russia Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 88 Russia Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 89 Russia Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 90 Russia Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 91 Spain Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 92 Spain Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 93 Spain Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 94 Spain Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 95 Spain Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 96 Spain Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 97 Spain Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 98 Spain Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 99 Spain Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 100 Spain Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 101 Spain Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 102 Spain Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 103 Italy Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 104 Italy Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 105 Italy Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 106 Italy Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 107 Italy Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 108 Italy Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 109 Italy Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 110 Italy Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 111 Italy Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 112 Italy Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 113 Italy Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 114 Italy Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 115 Rest of Europe Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 116 Rest of Europe Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 117 Rest of Europe Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 118 Rest of Europe Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 119 Rest of Europe Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 120 Rest of Europe Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 121 Rest of Europe Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 122 Rest of Europe Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 123 Rest of Europe Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 124 Rest of Europe Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 125 Rest of Europe Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 126 Rest of Europe Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 127 Key Information – Qiagen N.V.
TABLE 128 Key Information – Greiner Bio-One International GmbH
TABLE 129 Key Information – Sysmex Corporation
TABLE 130 Key information – Miltenyi Biotec B.V. & Co. KG
TABLE 131 Key Information – Bio-Techne Corporation
TABLE 132 Key Information – Ikonisys, Inc.
TABLE 133 Key Information – Menarini Silicon Biosystems SpA
TABLE 134 Key Information – LungLife AI Inc.
TABLE 135 Key Information – Aviva Systems Biology Corporation
TABLE 136 Key Information – ScreenCell
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Circulating Tumor Cell Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Circulating Tumor Cell Market
FIG 4 Porter’s Five Forces Analysis – Circulating Tumor Cell Market
FIG 5 Europe Circulating Tumor Cell Market share by Product, 2023
FIG 6 Europe Circulating Tumor Cell Market share by Product, 2031
FIG 7 Europe Circulating Tumor Cell Market by Product, 2020 - 2031, USD Million
FIG 8 Europe Circulating Tumor Cell Market share by End User, 2023
FIG 9 Europe Circulating Tumor Cell Market share by End User, 2031
FIG 10 Europe Circulating Tumor Cell Market by End User, 2020 - 2031, USD Million
FIG 11 Europe Circulating Tumor Cell Market share by Specimen, 2023
FIG 12 Europe Circulating Tumor Cell Market share by Specimen, 2031
FIG 13 Europe Circulating Tumor Cell Market by Specimen, 2020 - 2031, USD Million
FIG 14 Europe Circulating Tumor Cell Market share by Technology, 2023
FIG 15 Europe Circulating Tumor Cell Market share by Technology, 2031
FIG 16 Europe Circulating Tumor Cell Market by Technology, 2020 - 2031, USD Million
FIG 17 Europe Circulating Tumor Cell Market share by Application, 2023
FIG 18 Europe Circulating Tumor Cell Market share by Application, 2031
FIG 19 Europe Circulating Tumor Cell Market by Application, 2020 - 2031, USD Million
FIG 20 Europe Circulating Tumor Cell Market share by Country, 2023
FIG 21 Europe Circulating Tumor Cell Market share by Country, 2031
FIG 22 Europe Circulating Tumor Cell Market by Country, 2020 - 2031, USD Million
FIG 23 Swot Analysis: Qiagen N.V.
FIG 24 SWOT Analysis: Greiner Bio-One International GmbH
FIG 25 SWOT Analysis: Sysmex Corporation
FIG 26 Swot Analysis: Miltenyi Biotec B.V. & Co. KG
FIG 27 Swot Analysis: Bio-Techne Corporation
TABLE 2 Europe Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 3 Europe Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 4 Europe Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 5 Europe Kits & Reagents Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Kits & Reagents Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Devices Market by Country, 2020 - 2023, USD Million
TABLE 8 Europe Devices Market by Country, 2024 - 2031, USD Million
TABLE 9 Europe Blood Collection Tubes Market by Country, 2020 - 2023, USD Million
TABLE 10 Europe Blood Collection Tubes Market by Country, 2024 - 2031, USD Million
TABLE 11 Europe Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 12 Europe Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 13 Europe Research and Academic Institutes Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe Research and Academic Institutes Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Hospital & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Hospital & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Diagnostic Centers Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Diagnostic Centers Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 20 Europe Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 21 Europe Blood Market by Country, 2020 - 2023, USD Million
TABLE 22 Europe Blood Market by Country, 2024 - 2031, USD Million
TABLE 23 Europe Bone Marrow Market by Country, 2020 - 2023, USD Million
TABLE 24 Europe Bone Marrow Market by Country, 2024 - 2031, USD Million
TABLE 25 Europe Other Specimen Market by Country, 2020 - 2023, USD Million
TABLE 26 Europe Other Specimen Market by Country, 2024 - 2031, USD Million
TABLE 27 Europe Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 28 Europe Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 29 Europe CTC Detection & Enrichment Methods Market by Country, 2020 - 2023, USD Million
TABLE 30 Europe CTC Detection & Enrichment Methods Market by Country, 2024 - 2031, USD Million
TABLE 31 Europe CTC Analysis Market by Country, 2020 - 2023, USD Million
TABLE 32 Europe CTC Analysis Market by Country, 2024 - 2031, USD Million
TABLE 33 Europe CTC Direct Detection Market by Country, 2020 - 2023, USD Million
TABLE 34 Europe CTC Direct Detection Market by Country, 2024 - 2031, USD Million
TABLE 35 Europe Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 36 Europe Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 37 Europe Research, Clinical Market by Country, 2020 - 2023, USD Million
TABLE 38 Europe Research, Clinical Market by Country, 2024 - 2031, USD Million
TABLE 39 Europe Drug/Therapy Development Market by Country, 2020 - 2023, USD Million
TABLE 40 Europe Drug/Therapy Development Market by Country, 2024 - 2031, USD Million
TABLE 41 Europe Circulating Tumor Cell Market by Country, 2020 - 2023, USD Million
TABLE 42 Europe Circulating Tumor Cell Market by Country, 2024 - 2031, USD Million
TABLE 43 Germany Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 44 Germany Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 45 Germany Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 46 Germany Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 47 Germany Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 48 Germany Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 49 Germany Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 50 Germany Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 51 Germany Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 52 Germany Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 53 Germany Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 54 Germany Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 55 UK Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 56 UK Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 57 UK Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 58 UK Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 59 UK Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 60 UK Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 61 UK Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 62 UK Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 63 UK Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 64 UK Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 65 UK Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 66 UK Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 67 France Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 68 France Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 69 France Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 70 France Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 71 France Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 72 France Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 73 France Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 74 France Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 75 France Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 76 France Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 77 France Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 78 France Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 79 Russia Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 80 Russia Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 81 Russia Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 82 Russia Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 83 Russia Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 84 Russia Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 85 Russia Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 86 Russia Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 87 Russia Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 88 Russia Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 89 Russia Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 90 Russia Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 91 Spain Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 92 Spain Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 93 Spain Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 94 Spain Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 95 Spain Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 96 Spain Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 97 Spain Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 98 Spain Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 99 Spain Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 100 Spain Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 101 Spain Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 102 Spain Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 103 Italy Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 104 Italy Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 105 Italy Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 106 Italy Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 107 Italy Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 108 Italy Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 109 Italy Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 110 Italy Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 111 Italy Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 112 Italy Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 113 Italy Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 114 Italy Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 115 Rest of Europe Circulating Tumor Cell Market, 2020 - 2023, USD Million
TABLE 116 Rest of Europe Circulating Tumor Cell Market, 2024 - 2031, USD Million
TABLE 117 Rest of Europe Circulating Tumor Cell Market by Product, 2020 - 2023, USD Million
TABLE 118 Rest of Europe Circulating Tumor Cell Market by Product, 2024 - 2031, USD Million
TABLE 119 Rest of Europe Circulating Tumor Cell Market by End User, 2020 - 2023, USD Million
TABLE 120 Rest of Europe Circulating Tumor Cell Market by End User, 2024 - 2031, USD Million
TABLE 121 Rest of Europe Circulating Tumor Cell Market by Specimen, 2020 - 2023, USD Million
TABLE 122 Rest of Europe Circulating Tumor Cell Market by Specimen, 2024 - 2031, USD Million
TABLE 123 Rest of Europe Circulating Tumor Cell Market by Technology, 2020 - 2023, USD Million
TABLE 124 Rest of Europe Circulating Tumor Cell Market by Technology, 2024 - 2031, USD Million
TABLE 125 Rest of Europe Circulating Tumor Cell Market by Application, 2020 - 2023, USD Million
TABLE 126 Rest of Europe Circulating Tumor Cell Market by Application, 2024 - 2031, USD Million
TABLE 127 Key Information – Qiagen N.V.
TABLE 128 Key Information – Greiner Bio-One International GmbH
TABLE 129 Key Information – Sysmex Corporation
TABLE 130 Key information – Miltenyi Biotec B.V. & Co. KG
TABLE 131 Key Information – Bio-Techne Corporation
TABLE 132 Key Information – Ikonisys, Inc.
TABLE 133 Key Information – Menarini Silicon Biosystems SpA
TABLE 134 Key Information – LungLife AI Inc.
TABLE 135 Key Information – Aviva Systems Biology Corporation
TABLE 136 Key Information – ScreenCell
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Circulating Tumor Cell Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Circulating Tumor Cell Market
FIG 4 Porter’s Five Forces Analysis – Circulating Tumor Cell Market
FIG 5 Europe Circulating Tumor Cell Market share by Product, 2023
FIG 6 Europe Circulating Tumor Cell Market share by Product, 2031
FIG 7 Europe Circulating Tumor Cell Market by Product, 2020 - 2031, USD Million
FIG 8 Europe Circulating Tumor Cell Market share by End User, 2023
FIG 9 Europe Circulating Tumor Cell Market share by End User, 2031
FIG 10 Europe Circulating Tumor Cell Market by End User, 2020 - 2031, USD Million
FIG 11 Europe Circulating Tumor Cell Market share by Specimen, 2023
FIG 12 Europe Circulating Tumor Cell Market share by Specimen, 2031
FIG 13 Europe Circulating Tumor Cell Market by Specimen, 2020 - 2031, USD Million
FIG 14 Europe Circulating Tumor Cell Market share by Technology, 2023
FIG 15 Europe Circulating Tumor Cell Market share by Technology, 2031
FIG 16 Europe Circulating Tumor Cell Market by Technology, 2020 - 2031, USD Million
FIG 17 Europe Circulating Tumor Cell Market share by Application, 2023
FIG 18 Europe Circulating Tumor Cell Market share by Application, 2031
FIG 19 Europe Circulating Tumor Cell Market by Application, 2020 - 2031, USD Million
FIG 20 Europe Circulating Tumor Cell Market share by Country, 2023
FIG 21 Europe Circulating Tumor Cell Market share by Country, 2031
FIG 22 Europe Circulating Tumor Cell Market by Country, 2020 - 2031, USD Million
FIG 23 Swot Analysis: Qiagen N.V.
FIG 24 SWOT Analysis: Greiner Bio-One International GmbH
FIG 25 SWOT Analysis: Sysmex Corporation
FIG 26 Swot Analysis: Miltenyi Biotec B.V. & Co. KG
FIG 27 Swot Analysis: Bio-Techne Corporation